Latest News
Feature
FDA chief calls for stricter scrutiny of electronic health records
The government spent more than $36 billion over 10 years to switch to digital records. In that time, thousands of reports of deaths, injuries, and...
Video
BP control slowed brain damage in elderly hypertensives
NEW ORLEANS – Elderly hypertensive patients treated to a systolic blood pressure of 130 mm Hg had less white matter disease progression than...
Latest News
Biogen, Eisai discontinue aducanumab Alzheimer’s trials
All trials – the phase 3 ENGAGE and EMERGE trials, phase 2 EVOLVE safety study, and the long-term extension of the phase 1b PRIME study – have...
Conference Coverage
MedPAC puts Part B reference pricing, binding arbitration on the table
The reference pricing policy would set a maximum payment rate for a group of drugs with similar health effects based on the minimum, median, or...
Conference Coverage
Telerehabilitation is noninferior to in-clinic rehabilitation for poststroke arm function
HONOLULU – Participants in both study groups had significant gains in arm function and stroke knowledge at 30 days...
Conference Coverage
Intensive blood pressure lowering may not reduce risk of recurrent stroke
HONOLULU – Intensive treatment significantly reduces blood pressure, compared with standard treatment, and is...
Conference Coverage
Optical coherence tomography emerging as a promising biomarker for MS
DALLAS – To date, there has been a paucity of studies assessing the effects of DMTs on retinal layer thickness.
From the Journals
Will patient rewards for lower-cost choices impact physicians?
The rewards program offered $25-$500 for making lower-cost choices across 131 elective services.
Conference Coverage
New data bolster latitude’s association with MS prevalence
DALLAS – After integrating data from 94 new studies, “the latitudinal gradient in MS prevalence ... significantly enhanced in magnitude,”...
Video
Sex differences in MS: It’s the chromosomes, not just the hormones
Conference Coverage
Genetic signature helps identify those at risk of MS
DALLAS – “In this effort to redefine this disease and when it starts, these molecular and cellular studies are becoming very important.”